Alkermes | Investor Day Presentation Deck

Slide schematic 8/8

chart 4/4 list 1/1 paragraph 1/1 source-note 1/1 title 1/1

Components 8

dot dot dot dot bullet paragraph source-note headline

Tools 1

The slide presents a 2x2 matrix-like comparison of different treatment combinations (Vehicle, Lucitanib, Nemvaleukin*, Nemvaleukin* + Lucitanib) across various immune-related metrics.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide demonstrates synergistic effects of combination therapy on immune cell infiltration.